New evidence that toxic "spike protein" component of Covid-19 vaccines Our in-depth reporting reveals whats going on now to prepare you for whats coming next. . I have all of these on hand and I load up on vitamin D3 every day. Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. It doesnt get any better than this. He felt like he in good conscience had to speak out about covid, and so he made the decision to separate himself from M10, says Char, who has known Kirsch since the 1980s. Last Checked: 03/03/2023. If you are experiencing any odd adverse reactions, youll need to consult with your doctor ASAP. If you start later, doctors use higher dosages and compliance becomes a bigger problem. How covid-19 conspiracy videos keep getting millions of views. Mouse Systems is not a household word, he told the journalist. So how did a man once intent on furthering science become a source of misinformation that undermines the very research he funded? It could do nothing. Fluvoxamine is an inexpensive drug that has been in use for 37 years and has been used by an estimated 10 million people. The differences are obvious to untrained eyes. Dr. Joe Ladapo wrote a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients." Fluvoxamine at 50mg twice a day for 14 days is a very well-tolerated drug (as long as you avoid caffeine and alcohol) for the treatment of COVID infections. Every year, we pick the 10 technologies that matter the most right now. The effect size is huge if the drug is given early right after symptoms start. It cant be more clear than this. Summarizes the 5 observational studies, RCT, RWE, and some of the more interesting anecdotal data. Hes very convincing. Peter Meinke, another former board member, spent nearly three decades in drug discovery at Merck. Fluvoxamine, created 37 years ago, is an inexpensive and widely available generic drug. That is when the phase 2 results were published. I've asked people, "there's a lot of evidence here it's not just a small phase 2 RCT. The anecdotal data of 100% success rates is further icing on the cake. The Wall Street Journal thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). From the French observational data (see the very last page), it appears that the biggest effect is limiting serotonin release (any SSRI will do that). So you can address your OCD and if you get COVID, youll can up the dose. Here are my answers. While combining the results of several well-designed trials can strengthen an argument or unearth patterns unseen in smaller samples, a meta-analysis is just the sum of its parts; any single well-done experiment is more useful than combining the results of several poorly done ones. With covid, 80% of your patient population does just peachy with no treatment at all, just a little bed rest and fluid. Dose escalation studies in lupus patients and in rheumatoid arthritis patients established that 800 mg per day for life and 1,200 mg per day for 6 weeks are extremely well-tolerated. . As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. Please read and agree to the disclaimer before watching this video.. Steve Kirsch On COVID Early Treatment and CensorshipSteve Kirsch is an entrepreneur and . Delta vocus Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. This advice is now outdated. Since making a fortune as the founder of Infoseek, an early search engine that was the Google of its day, Kirsch has spent tens of millions of dollars fighting humanitys biggest threats. Fluvoxamine as a potential treatment for Covid - The External Medicine Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. Their The other doctors aren't using it either because they don't know about it or fear doing anything not approved by the CDC for treating COVID. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. Kirsch: Yes, but you could easily watch that 60 Minutes story and believe that we need more data before people should start using fluvoxamine. Thats pretty typical, but your mileage may vary. . A Cross-Sectional Study on the Personality Traits of Episodic and She understands complex, politicized pandemicsshe was one of the first clinicians to specialize in HIV/AIDS, and she sat on the FDA advisory panel that approved the first antiretroviral drug. When the pandemic started, he created the COVID-19 Early Treatment Fund (CETF) to fund researchers working on repurposed drugs including fluvoxamine which reduces death from COVID by a factor of 12. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. Silicon Valley entrepreneur Steve Kirsch urges the FDA to quickly Immediately after the results of the first fluvoxamine trial were releasedbut before they were published in a peer-reviewed journalhe wrote a post on Medium.com called The Fast, Easy, Safe, Simple, Low-Cost Solution to COVID That Works 100% of the Time That Nobody Wants to Talk About.. . Fluvoxamine (Luvox) is a Selective Serotonin Receptor Inhibitor (SSRI) that is clinically indicated for OCD in children, and can be used off label for depression. I took it myself at that dosage and noticed zero side effects. Yes, these were successes, but the successes could have been bigger if we had really paid attention to marketing. The drug was FDA-approved more than 65 years ago. Although there is evidence that fluvoxamine can prevent clinical worsening and the need for hospitalizations in outpatients with early covid-19, I have seen no good evidence that fluvoxamine is useful as a substitute for the vaccines, co-investigator Angela Reiersen wrote to me. An approach that promised to democratize design may have done the opposite. And, according to three members of CETF's scientific advisory board, he put pressure on them to promote fluvoxamine for clinical use without conclusive data that it worked for . Since then, he has continued to promote fluvoxamine, along with ivermectin and hydroxychloroquine. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Steve Kirsch: $25,000 to Anyone that Proves Fluvoxamine - TrialSiteNews It is currently approved for treatment of depression and obsessive compulsive disorder (OCD). Substitutions. It was completed in August. I see it all the time on social media, Morris told me. Kirsch and his wife, Michele, fund a charitable foundation, which by 2007 had given $75 million to different causes. That way you can start immediately. Dr. Eric Lenze: So the results were really pretty. Food/drugs to avoid while on fluvoxamine. My publicly shared concerns regarding the safety of the COVID-19 vaccines may have had a negative impact on my company, M10. Kirsch, despite having direct access to the actual trial runner, eventually became convinced a correct interpretation of the data would show that hydroxychloroquine worked. Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid. Reason is the hospital gets release from liability if they follow NIH guidelines. Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Vaccine waitlist Dr. B collected data from millions. After one or two conversations like that, I got tired of arguing, so I started avoiding his calls.. 22, 2021, 9:00 a.m. Steve Kirsch , a former tech entrepreneur who earned a fortune worth up to $300 million, has been showcased on TrialSite a few times for his activity supporting the clinical development of repurposed drugs for COVID-19 treatments. As Kirsch has gone deeper into the anti-vaccine scene, many professional associates have increasingly distanced themselves from him. But they dont want their names used. Fluvoxamine data for COVID-19 Treatment - COVID-19 Early Treatment Fund We are ignoring the advice of the KOL group and doing nothing. The medical community did nothing (with a few exceptions like Dr. Seftel). He considers himself an expert in something that he doesnt have training or experience in, and hes not following scientific methods to assess data.. While Kirsch had the final say in who received grants, no one I spoke with expressed concerns about what projects had been funded, or why. So much for evidence-based medicine. In every case we are aware of, the drug was successful in reversing COVID symptoms, generally in 3 days or less. Here are the key things you should know about fluvoxamine for COVID: It works. Steve Kirsch On COVID Early Treatment and Censorship - YouTube What has alarmed many of the scientists associated with CETF, though, are Kirschs reactions to the work hes fundedboth successes and failures. So instead of this paper being treated as confirming an earlier hypothesis, it was treated as generating a novel hypothesis. I fully expected both organizations to do absolutely nothing. There are at least eight mechanisms of action that we think contribute to the effectiveness of this drug. (The ivermectin data are trash, Feinberg told me. 12:45 AM . P-value was 10^-14 on that study (done by Dr. After I ended the Zoom meeting, Satterfield called me to apologize for cutting us off. Everyone says "we need more data" to show fluvoxamine works for COVID. Its motivated out of his sense of keeping people safe and advancing health care.. Drug interactions should be checked for. Download Citation | On Mar 1, 2023, Gne Seda Albayrak and others published A Cross-Sectional Study on the Personality Traits of Episodic and Chronic Migraine Patients | Find, read and cite all . If you start 5 days after symptoms, all bets are off. In three phone conversations, as well as dozens of emails, his responses to questions about claims in this story were imprecise or constantly changing. Fluvoxamine is way better than Molnupiravir, but the NIH doesnt approve drugs on effectiveness. If you were drowning and we had no known standard of care to save your life and someone had a life preserver which worked 160 times in a row, should we throw them the life preserver or let them drown because we aren't absolutely sure the life preserver's benefit > risk (since just because it worked 160 times in a row and there is a 99.99% chance the effect didn't happen by chance, we could have just gotten lucky). The medical community doesnt care about saving lives. Antidepressant fluvoxamine could keep mild COVID-19 from worsening Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. The post read: "I will be featured on 60 Minutes this Sunday talking about fluvoxamine as an effective treatment for COVID-19 to prevent hospitalization and death. This was shown to be very tolerable (no side effects in 99% of patients) and extremely effective (no hospitalizations and death if you start it ASAP after first symptoms). MD, MPH; Steven C. Marcus, PhD. Fluvoxamine has a 40 year safety track record. We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. In September, Kirsch emailed Morris asking him to estimate the maximum number of deaths caused by vaccines. I fully expected both organizations to do absolutely nothing. There may be a depression of libido while on drug, but since the drug is taken on acute basis, this is only temporary and it reverses once the drug is stopped. We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. Waiting months for the phase 3 trial to complete is nuts. But I know something else that few other people know, thanks to a source at the NIH: the NIH was planning to approve fluvoxamine months ago, but they got a call from the FDA telling them not to. Dosing. Were having trouble saving your preferences. Steve Kirsch. Molnupiravir followed patients for only 30 days because they know the drug is dangerous. Some countries dont have fluvoxamine so this is the alternative. 4000fluvoxamine750 Please, As of November 13, fluvoxamine has been proven to work in every trial that has published results, including, studies. Keyword: ivermectin It's hard to ignore this lecture in explaining why the drug is so effective. By Steve Kirsch Last updated: March 14, 2021 After I appeared on the60 Mi nut es story about fluvoxamine,I've received a lot of questions from people about how to treat COVID. The web value rate of skirsch.io is 2 . Those days are gone. This alone will give roughly a 50% effect size and explains why all of the the SSRIs are effective including those that do not activate the Sigma1 receptor (e.g., Paroxetine). I couldn't agree more. just like ivermectin). Please. CETF was founded by entrepreneur and philanthropist Steve Kirsch, as a way to expedite the fight against COVID-19. This is quite stunning because the PK of the drug done at the Gates Foundation shows it only reaches 50% of the final concentration after 3 days. He may not be a good scientist, but hes smart, says WVUs Feinberg. While YouTube has repeatedly taken down the full video of the DarkHorse episode, various clips have been watched over 4 million times, and the full audio remains available on Spotify. Infoseek lost out to Yahoo; it had a chance to grow bigger, but it didn't. FDA official fluvoxamine rejection. Opinion: The urgency for vaccinations | The Northside Sun If you cant get a prescription for COVID, then perhaps you have OCD? He is the inventor of the optical mouse and one of the first Internet search engines, Infoseek. 90,000 people don't have to die in the next 3 weeks. This is the #1 ranked best answer to "COVID treatment" on Quora: Presentation on how fear of trying something new is what keeps us shutdown and leads to unnecessary loss of life: The Lenze fluvoxamine RCT that was published in JAMA on November 12, 2020 showed a 100% success rate in preventing hospitalization. Keyword: mit That way you can start immediately. There are two ways Ive discovered that I may be able to save the world, he told an IEEE Spectrum reporter in 2000. If you cant lay off the java, then try fluoxetine (Prozac). Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. You will be wired for 24 hours if you dont heed my advice. The group who declined the drug were very sick with 12.5% requiring hospitalization and one died. The study was also featured on 60 Minutes. This give another 50% of benefit. Ive used it personally at 50mg twice a day and experience no adverse events at all. And while Morris believes that all claims about vaccine safety should be properly vettedIs it possible theres another rare side effect of the vaccines that we havent figured out yet? The NIH never did a risk benefit analysis of this drug. But an Editor's Note urged physicians to treat this as a hypothesis and not as a basis for clinical decision-making. The data we have today with just 2 clinical trials (RCT and confirmatory RWE) is compelling. Today, we are letting people drown and we are not even telling them there is a life preserver they can ask for today with compelling evidence that is under consideration by the life preserver safety group. My favorite dosage is 50mg twice a day for 14 days. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. Article about the rejection (Stat News) Article about the fluvoxamine rejection (The Verge) NIH is still unsure whether fluvoxamine should be used to treat COVID (article I did after the TOGETHER trial). This story is part of the Pandemic Technology Project, supported by The Rockefeller Foundation. Medium revoked my account for life. Weve known it works since August 24, 2020. They left their recommendation of fluvoxamine at NEUTRAL. Added to FLCCC protocols and Fareed-Tyson protocol among others. It is in a class of drugs known as selective serotonin-reuptake inhibitors (SSRIs), but unlike other SSRIs, fluvoxamine interacts strongly with a protein called the sigma-1 receptor. are all super cheap, effective, and available without a prescription. They immediately ruled out the vaccine, because the vaccine is, quote, safe.. If you continue to get this message, Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. has tons of info on fluvoxamine with all the links. Steve Kirsch is a Silicon Valley philanthropist. Saving the world has been a theme of Kirschs life for years. 47).. So it was both obvious and convincing the difference between the groups to the workers and the track management. Keeping this drug off the NIH Guidelines does nothing to reduce the death rate. If you start later, doctors use higher dosages and compliance becomes a bigger problem. For example all of these combos should have near 100% success against hospitalization, death, and long-haul COVID symptoms: Proxalutamide and fluvoxamine Skirsch.io traffic volume is 1,957 unique daily visitors and their 3,914 pageviews. The evidence is solid. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. . . Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. Over the last 18 months, the fund has granted at least $4.5 million to researchers testing the covid-fighting powers of drugs that are already FDA-approved for other diseases. Fluvoxamine works on hospitalized patients too, but no US hospital will let you use it (sound familiar? It has shown to be 100% protective of hospitalization in 2 clinical trials. Should I take ivermectin or fluvoxamine or both? - Quora All have had a 100% success record in keeping their patients out of the hospital. Completely avoid caffeine, alcohol, tylenol, and benadryl. If you start 5 days after symptoms, all bets are off. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. Earlier that month, Seftel had heard about fluvoxamine during a presentation by tech entrepreneur Steve Kirsch, whose COVID-19 Early Treatment Fund supports research on existing drugs that could . He has been a medical philanthropist for more than 20 years. About - vacsafety.org Elsewhere he has said he began questioning vaccine safety after an unnamed Twitter follower told him several family members died after getting their shots. Or just depression about the vaccine mandates? . The race to find covid-19 drug treatments that actually work, The antimalarial drug Trump took for covid might actually be dangerous. Telling the truth, he tweeted. It was tested in. He retired at the largest pension in federal history. All can merit a fluvoxamine prescription based on traditional diagnoses. They never make things worse so are safe to try. O, Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19 | Blood Advances | American Society of Hematology, Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Fluvoxamine for COVID-19 Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008, Drug Repurposing Research Leads to Potentially Game-Changing Treatment to Prevent Clinical Deterioration in Outpatients With COVID, The Covid-19 Early Treatment Fund was launched to provide funding for research in order to, Steve Kirschs answer to What is the current treatment for Covid-19? The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing).
